BALA CYNWYD, Pa., March 26, 2016 /PRNewswire/ -- Law Office of Brodsky & Smith, LLC announces an investigation of Insys Therapeutics, Inc. ("Insys" or the "Company") (Nasdaq -INSY- News) for potential violations of federal securities laws and breaches of the Insys Board's fiduciary duties.
Click here to learn more about the investigation http://brodsky-smith.com/1054-insy-insys-therapeutics-inc.html, or call: 877-534-2590. There is no cost or obligation to you.
The investigation concerns a securities class action lawsuit commenced in the United States District Court for the District of Arizona. The complaint alleges that: (i) the Defendants made false and misleading statements including failing to disclose that the Company was engaged in the illegal and improper off-labeling marketing of Subsys; (ii) certain Insys employees were complicit in an illegal kickback scheme operated for the purpose of increasing prescriptions of Subsys; and (iii) as a result, the Company's financial statements were materially false and misleading at all relevant times. Following the disclosure of these facts, shares of Insys stock declined significantly.
If you purchased shares of Insys between March 3, 2015 and January 25, 2016, and wish to discuss the investigation, or if you have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC by March 21, 2016, who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at firstname.lastname@example.org, by visiting http://brodsky-smith.com/1054-insy-insys-therapeutics-inc.html, or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders.
Attorney advertising. Prior results do not guarantee a similar outcome.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-law-office-of-brodsky--smith-llc-announces-investigation-of-insys-therapeutics-inc---insy-300241682.html
SOURCE Brodsky & Smith, LLC